Medication Safety Gap Persists for Seniors With Cognitive Decline

A University at Buffalo analysis of 2,796 independently living adults aged 65 and older with cognitive disorders found that exposure to potentially inappropriate central nervous system medications fell from 39.3% in 2011 to 29.3% in 2022. Still, almost one-third received at least one such drug, which can worsen memory, balance, and coordination and increase hospitalization and death risks. The researchers highlight deprescribing—reducing, stopping, or replacing risky medications—as a way to lower harm.
EXPANDED:
Researchers at the University at Buffalo studied 2,796 independently living people aged 65 and older with cognitive disorders. From 2011 to 2022, the proportion exposed to risky central nervous system medicines fell from 39.3% to 29.3%. The analysis represented roughly 29.7 million older Americans with such conditions during